Senior Investigator, Lady Davis Institute
Chief, Department of Obstetrics & Gynecology and Division of Gynecologic Oncology, Jewish General Hospital
Professor of Ob-Gyn and Oncology, McGill University
Walter H. Gotlieb completed his medical degree summa cum laude at the Université Libre de Bruxelles, in his native Belgium, where he went on to obtain board certification in Ob-Gyn. Following two years at the National Institutes of Health, where he obtained the National Cancer Institute Award of Outstanding Performance, he obtained a three year fellowship in Gyn-onc at UCLA. He was then recruited by the by Tel Aviv University, Tel Hashomer Hospital, where he co-founded and built up the Department of Gynecologic-Oncology from 1994 to 2003.
In 2003, he was recruited by McGill University. He obtained licenses to practice in Europe, Israel, California, and Canada.
Dr. Gotlieb sits on the Executive Committee for the Society of Gynecologic Oncologists of Canada, and Organizing Committee for the International Gynecologic Cancer Society meeting He is senior editor of the International Journal of Gynecologic Cancer. His prior involvements with medical societies includes the council of the International Gynecologic Cancer Society, the Israel Gynecologic Oncologists, the secretary treasurer of the Society of Gynecologic Oncologists (SGO) of Canada, the SGO 2006 program committee, the International Committee of the SGO, and Vice President of the Association des gynécologues oncologues du Québec.
Dr. Gotlieb is presently Professor of Ob-Gyn and of Oncology at McGill University. He is the Chief, Department of Obstetrics & Gynecology and Division of Gynecologic Oncology at the Segal Cancer Center of the Jewish General Hospital, and Director of Surgical Oncology at McGill University.
He recently completed an executive course in health care management and delivery at the Harvard Business School.
Major Research Activities
In addition to his clinical responsibilities, he is involved in scientific research in ovarian cancer as a Project Director at the Lady Davis Research Institute. Together with his team, and particularly Dr. Lau, they have pioneered the use of robotic surgery in gynecologic cancer in Canada. He has lectured around the world, and has proctored robotic surgery multiple times in Canada, China, India and Israel. A recipient of thirteen national and international awards in the area of cancer research, Dr. Gotlieb is widely published, with over 150 peer-reviewed manuscripts in reputable international journals.
Leung A, Abitbol J, Ramana-Kumar AV, Fadlallah B, Kessous R, Cohen S, Lau S, Salvador S, Gotlieb WH. Outside the operating room: How a robotics program changed resource utilization on the inpatient Ward. Gynecol Oncol. 2017 Apr;145(1):102-107. doi: 10.1016/j.ygyno.2017.01.034. Epub 2017 Feb 4.
Kessous R, Laskov I, Abitbol J, Bitharas J, Yasmeen A, Salvador S, Lau S, Gotlieb WH. Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol. 2017 Mar;144(3):474-479. doi: 10.1016/j.ygyno.2016.12.017. Epub 2016 Dec 29.
Greenwald ZR, Huang LN, Wissing MD, Franco EL, Gotlieb WH. Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer? Cancer. 2017 May 1;123(9):1545-1554. doi: 10.1002/cncr.30529. Epub 2016 Dec 27.